Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Medtronic plc (MDT:NYSE), powered by AI.
Medtronic plc is currently trading at $81.32. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Medtronic plc on Alpha Lenz.
Medtronic plc's P/E ratio is 22.4.
“Medtronic plc trades at a P/E of 22.4 (fair value) with solid ROE of 9.5%.”
Ask for details →Medtronic plc is a leading global healthcare technology company that designs, manufactures, and sells innovative medical devices and therapies used in various medical procedures. The primary function of Medtronic is to improve healthcare outcomes by providing advanced therapeutic solutions. Its extensive product portfolio includes cardiac and vascular devices, diabetes-related products, minimally invasive therapies, and neurosurgical technologies. Medtronic plays a vital role in the medical device industry, catering to cardiovascular treatment, advanced diabetes management, spinal and musculoskeletal therapy, and more. Notably, the company is renowned for its pacemaker technology and is a pivotal player in cardiac care. The company's innovations significantly impact the healthcare sector by enhancing the quality of life for patients worldwide and improving the effectiveness of medical treatments. As a key player in the medical device market, Medtronic is instrumental in setting industry standards and advancing medical technology through continuous research and development. Founded in 1949 and headquartered in Dublin, Ireland, Medtronic's global presence underscores its substantial contribution to the healthcare industry across various continents.
“Medtronic plc trades at a P/E of 22.4 (fair value) with solid ROE of 9.5%.”
Ask for details →Medtronic plc (ticker: MDT) is a company listed on NYSE in the Healthcare sector (Medical Devices). It has approximately 95,000 employees. Market cap is $104.5B.
The current price is $81.32 with a P/E ratio of 22.42x and P/B of 2.18x.
ROE is 9.49% and operating margin is 19.50%. Annual revenue is $33.5B.